ReviewStem cell reviews and reports2010
Progress and promise towards safe induced pluripotent stem cells for therapy.
Review in Stem cell reviews and reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 60 citations in OpenAlex.
- Bioactive materials forBioactive materials · 2024Review
- TGFβ superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoids.Stem cell reports · 2022Article
- Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System.Iranian journal of pharmaceutical research : IJPR · 2021Review
- An Insight into Reprogramming Barriers to iPSC Generation.Stem cell reviews and reports · 2020Review
- A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.Journal of hematology & oncology · 2016Article
- The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.Current protocols in toxicology · 2016Review
- An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.International journal of molecular sciences · 2016Review
- Direct reprogramming and biomaterials for controlling cell fate.Biomaterials research · 2016Review
- Human induced pluripotent stem cells labeled with fluorescent magnetic nanoparticles for targeted imaging and hyperthermia therapy for gastric cancer.Cancer biology & medicine · 2015Article
- Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.Experimental biology and medicine (Maywood, N.J.) · 2015Review
- Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach.PloS one · 2015Article
- In vitro neurogenesis: development and functional implications of iPSC technology.Cellular and molecular life sciences : CMLS · 2014Review
- Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment.Journal of tissue engineering · 2014Review
- Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells.Molecular biotechnology · 2013Article
- Thinking outside the liver: induced pluripotent stem cells for hepatic applications.World journal of gastroenterology · 2013Review
- Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.PloS one · 2013Article
- Non-genetic modulation of Notch activity by artificial delivery of Notch intracellular domain into neural stem cells.Stem cell reviews and reports · 2012Article
- Converted neural cells: induced to a cure?Protein & cell · 2012Review
- Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering.Stem cells international · 2012Article
- Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.Anatomy & cell biology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.